MMP13 and ovarian carcinoma: Overexpression of MMP13, along with CGA, EPHA3, PSMD9, PITX2, and PHLPP1, has been associated with poor response to platinum-based chemotherapy in patients with high-grade serous ovarian cancer (HGSOC), the most aggressive form of ovarian cancer (114).